Sam68 is required for the growth and survival of nonmelanoma skin cancer

Abstract

Although targeting DNA repair signaling pathways has emerged as a promising therapeutic for skin cancer, the relevance of DNA damage responses (DDR) in the development and survival of nonmelanoma skin cancer (NMSC), the most common type of skin cancer, remains obscure. Here, we report that Src‐associated substrate during mitosis of 68 kDa (Sam68), an early signaling molecule in DDR, is elevated in skin tumor tissues derived from NMSC patients and skin lesions from Gli2‐transgenic mice. Downregulation of Sam68 impacts the growth and survival of human tumor keratinocytes and genetic ablation of Sam68 delays the onset of basal cell carcinomas (BCC) in Gli2‐transgenic mice. Moreover, Sam68 plays a critical role in DNA damage‐induced DNA repair and nuclear factor kappa B (NF‐κB) signaling pathways in keratinocytes, hence conferring keratinocyte sensitivity to DNA damaging agents. Together, our data reveal a novel function of Sam68 in regulating DDR in keratinocytes that is crucial for the growth and survival of NMSC.

INTRODUCTION

Skin cancer is the most commonly diagnosed malignancy in the United States, and the incidence of skin cancer has increased dramatically over the last few decades. Nonmelanoma skin cancer (NMSC), which includes squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs), is the most common type of skin cancer and is associated with significant morbidity and mortality. It has been well documented that DNA damage frequently caused by irradiation in keratinocytes and melanocytes plays a crucial role in the initiation and progression of skin cancer in high‐risk individuals ; however, the relevance of DNA damage responses (DDR) in tumor skin keratinocytes has not been extensively investigated yet.

Skin cancer cells, similar to other types of cancer cells, are continuously challenged by intrinsic stresses including the accumulation of replication errors in rapidly proliferating cells that could ultimately add to the DNA damage burden. In order to conquer this intrinsic DNA damage and avoid the programmed cell death associated with it, cancer cells generally acquire an elevated DNA repair capability through a hyperactivated DDR machinery. Targeting DDR processes can induce antitumor effects when used as a monotherapy or in combination with other therapies in various tumor settings. In particular, recent studies have shown signs of promise when inhibiting poly(ADP‐ribose) polymerase 1 (PARP1) conferred DDR in melanoma. Whether DDR plays an important role in the development and survival of NMSC and whether it could be therapeutically targeted in NMSC remain largely unknown. Our recent studies reveal that Src‐associated substrate during mitosis of 68 kDa (Sam68) is an early‐onset and key effector of the response to DNA damage. Elevated expression of Sam68 occurs in multiple types of cancers and also correlates with tumor progression. Sam68 is ubiquitously expressed in many tissues including the skin ; however, the significance of Sam68 in skin cancer development and survival has not yet been examined.

In this paper, we show that the steady‐state levels of Sam68 are elevated in the skin tumors derived from human BCC and SCC patients and in skin tumor lesions from genetically manipulated Gli2^tg/+ mice. Ablation of Sam68 dramatically delays the spontaneous onset of tumor lesions in Gli2^tg/+ mouse ears. Moreover, Sam68 knockdown attenuates DNA damage‐induced DNA repair and NF‐κB signaling pathways, suggesting a key role of Sam68 in DDR in keratinocytes. Collectively, our findings reveal a crucial role of Sam68 in the development and survival of NMSC through regulating multiple signaling pathways in DDR.

MATERIALS AND METHODS

Ethics statement

All animal experiments were performed according to protocol number MO16H285, approved by the Johns Hopkins University's Animal Care and Use Committee and in direct accordance with the NIH guidelines for housing and care of laboratory animals. Human skin cancer tissue arrays were purchased from US Biomax Inc, where all human tissues have been collected under HIPAA‐approved protocols with donors being informed in full and with their consent. All samples tested negative for HIV and Hepatitis B or their counterparts in animals, and approved for commercial product development (see Table S1 for additional details).

Mice

Sam68^−/− and Gli2^tg/+ mice in C57Bl/6 background were described previously. Gli2^tg/+; Sam68^± mice were bred with Sam68^± mice to generate the progeny of interest. All mice were maintained in a specific pathogen‐free facility and fed autoclaved food and water ad libitum.

Cell culture, antibodies, and reagents

Immortalized mouse epidermal keratinocytes cells and A431 human malignant keratinocytes, regularly tested for mycoplasma contamination, were cultured as described previously. Antibodies used were: IκBα, Sam68, p65 from Santa Cruz Biotechnology; β‐actin from Sigma‐Aldrich; PECAM‐1 from Chemicon; PAR from Trevigen; phospho‐p65, Chk1, phospho‐Chk1, Chk2, Histone H3, phospho‐H3 from Cell Signaling Technology; phospho‐Chk2 from Novus Biologicals; 4′,6‐diamidino‐2‐phenylindole (DAPI) was obtained from Sigma‐Aldrich. Human tissue arrays containing skin tissue samples derived from healthy controls and squamous and basal cell carcinoma patients were purchased from US Biomax Inc.

Flow cytometry

For flow cytometry, cells were washed twice with PBS, resuspended in staining buffer (1% fetal bovine serum in PBS), and stained with annexin V/propidium iodide. Following staining and extensive washes with staining buffer, cells were analyzed on a FACSCalibur (BD Biosciences). Events were collected and analyzed with the FlowJo software (Tree Star).

γ‐Irradiation

γ‐Irradiation of A431 cells and immortalized keratinocytes was performed using a ¹³⁷Cesium source (dose rate 8 Gy/min) as previously described.

RNA interference and transfection

Mouse Sam68 siGENOME SMARTpool siRNA was purchased from Thermo Scientific. Human Sam68 siRNAs were described previously. Transient transfection of siRNAs into mouse/human keratinocytes was performed with Lipofectamine RNAiMAX (Life Technologies) according to the manufacturer's instructions.

Cell survival assays

After knockdown of Sam68 for 72 hours, 1 × 10³ of cells were γ‐irradiated at the indicated dose and immediately seeded in six‐well plate. After incubation for an additional 96 hours, surviving cells were counted using a Z1 Coulter Particle Counter (Beckman Coulter), and the survival fraction was calculated by normalizing the live cell numbers from indicated samples to that in nonradiated si‐NC cells.

Anchorage‐independent growth in soft agar

5 × 10⁴ cells suspended in 750 μL of DMEM containing 20% FBS were combined with 750 μL of 0.6% (w/v) agarose. This 0.3% agar/cell solution was plated on top of a 2‐ml layer of 0.5% agarose in one well on a six‐well plate. After 5 minutes, 500 μL of DMEM was added to cover the solidified agar/cells, and replaced with fresh medium every 3 days to prevent wells from drying out. Three weeks later, colonies were obtained using the FluorChem Q imaging system, and light intensity was adjusted to specifically show colonies in dark shades. Images were then processed using the ImageJ software (National Institutes of Health) to quantify colony number and diameter.

Immunoblot

Immunoblot assays were conducted as previously described. In brief, cells were harvested and lysed on ice by 0.4 mL of lysis buffer (50 mmol/L Tris‐HCl [pH 8.0], 150 mmol/L NaCl, 1% NP‐40, and 0.5% sodium deoxycholate, 1× complete protease inhibitor cocktail [Roche Applied Science]) for 30 minutes. The proteins were separated by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes and probed by the Super Signaling system (Thermo Scientific) according to the manufacturer's instructions, and imaged using a FluorChem E System (Protein Simple).

Histology and immunohistology

After euthanizing mice, ear tissue was removed under aseptic conditions, fixed in 10% buffered formalin for 24 hours, embedded in paraffin and 5‐micron sections were then cut and processed for Hematoxylin and Eosin (H&E) staining. For immunohistology, after euthanizing mice, ear tissue was excised under aseptic conditions and frozen in optimal cutting temperature (OCT) media (Tissue‐Tek). Five micron frozen sections were cut using a Microm HM 550 Cryostat (Thermo Scientific), collected on coated slides, fixed in paraformaldehyde, washed with PBS, and blocked with appropriate sera in PBS. After incubating with appropriate antibodies, sections were washed and incubated with fluorescence dye‐conjugated second antibodies and 1 µg/mL of DAPI. Stained sections were washed and mounted under a coverslip using Fluoro‐gel with Tris Buffer (Electron Microscopy Sciences) and examined using a DMi8 fluorescent microscope (Leica). The measurement of ear thickness was carried out as described.

Statistical analyses

All statistical analyses were performed using GraphPad Prism version 6.0 (GraphPad Software). Standard errors of the mean (SEM) were plotted in graphs. Differences are reported as follows: ns, nonsignificant difference; * different at P < .05; ** at P < .01; *** at P < .001; **** at P < .0001 by unpaired Student's t test.

RESULTS

Sam68 protein levels are elevated in human and mouse nonmelanoma skin cancer

To assess the potential relevance of Sam68 in NMSC, we first examined Sam68 expression in human skin tissue samples derived from either healthy controls or NMSC patients. The protein levels of Sam68 were substantially elevated in the skin tissue from 16 BCC and 17 SCC patients, when compared to those in normal skin tissue from healthy controls (Figure A,B). We further measured Sam68 protein levels in skin tissue derived from Gli2‐transgenic (Gli2^tg/+) mice, which spontaneously develop basaloid follicular hamartoma lesions between postnatal 45 days (P45) and P120 that then become more like nodular BCC observed in human BCC patients by around P180. Consistently, Sam68 was upregulated in lesions in the ear skin derived from Gli2^tg/+ mice, compared to the normal skin tissue derived from wild‐type (WT) mice (Figure C) or the adjacent normal tissue from the same tumor‐laden Gli2^tg/+ mice (Figure D). Moreover, we examined when Sam68 protein levels elevated during the course of spontaneous skin tumor development in Gli2^tg/+ mice, by examining the relative Sam68 protein levels in the ear tissues from wild‐type and Gli2^tg/+ mice at various periods after birth. Indeed, while the relative levels of Sam68 maintained comparable in WT mouse skin tissues ranging from P20 to P100, they substantially increased in Gli2^tg/+ mouse ear skin at P40 and such elevation was more profound at P60 and thereafter (Figure E). These results suggest that the elevated Sam68 protein levels correlate with, and thus could contribute to, the development of human and mouse NMSC.

Sam68 protein level is elevated in human and mouse skin cancers. A, Immunofluorescence micrographs of Sam68, with nuclei counterstained by DAPI, on skin tissue sections from healthy controls or nonmelanoma skin cancer (NMSC) patients consisting of both squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) cases. T, tumor; derm, dermis; epi, epidermis. Scale bars, 100 μm. Right, the fluorescence intensity (FI) of Sam68 on the indicated skin tissue sections was quantified. B, Hematoxylin and eosin staining of human healthy control skin, SCC, and BCC tissues. Scale bars, 500 μm. C, Immunofluorescence micrographs of Sam68, with nuclei counterstained by DAPI, on normal and tumor skin tissue sections from wild‐type (WT) and tumor‐laden Gli2tg/+ mice, respectively. T, tumor; derm, dermis; epi, epidermis. Scale bars, 50 μm. D, Whole cell lysates derived from adjacent normal (N) and tumor (T) skin tissue from the same tumor‐laden Gli2tg/+ mice at postnatal day 60 were immunoblotted (IB) for Sam68, with Histone H3 as a loading control. Bottom, normalized Sam68 level in the N and T skin tissues in Gli2tg/+ mice (n = 3) was quantified. E, Skin tissue was collected from wild‐type mice or Gli2tg/+ mice at the indicated postnatal days and whole cell lysates were derived (each sample indicates individual mouse) and IB for Sam68, with β‐actin as a loading control. The normalized Sam68 level in the skin of indicated mice was quantified on the bottom. Protein expression levels were measured from at least three mice per genotype/time point. AU, arbitrary unit. Data information: In (A, D‐E), data are presented as mean ± SEM. *P < .05; **P < .01; and ***P < .001 (Student's t test)

Sam68 is crucial for the growth and survival of human skin cancer cells

To assess the impact of Sam68 on the cell growth and survival of NMSC, we downregulated Sam68 expression in A431 cells, a human malignant keratinocyte cell line, using small interference RNAs (siRNAs). As expected, Sam68‐specific siRNA transfection significantly reduced Sam68 level in A431 cell (Figure A). Interestingly, Sam68 knockdown, in comparison to nonspecific controls, substantially sensitized A431 cells to undergo programmed cell death spontaneously, with increased percentages of early (Annexin V⁺PI⁻) and late (Annexin V⁺PI⁺) apoptotic cells, as analyzed by Annexin V and propidium iodide (PI) staining (Figure B). To further assess the impact of Sam68 on the oncogenic transformation properties of A431 cells, we carried out anchorage‐independent colony formation (soft agar) assays, which have been widely used to evaluate the loss of contract inhibition of growth, a hallmark of cancer cells. Substantially less colonies that otherwise showed reduced growth areas grew within the soft agar from A431 cells expressing Sam68‐specific siRNA compared to the nonspecific controls (Figure C‐E). Application of the EdU cell proliferation assay showed that knockdown of Sam68 has no significant influence on proliferation of A431 cells (Figure S1). Taken together, these results suggest that Sam68 plays an important role in the growth and survival of human NMSC cells.

Sam68 is essential for survival and growth of skin cancer cells. A, A431 cells were transfected with nonspecific control (si‐NC) or Sam68‐specific (si‐Sam68) small interference RNAs. Seventy‐two hours later, whole cell lysates were derived and immunoblotted (IB) for Sam68, with β‐actin as a loading control. B, A431 cells expressing si‐NC or si‐Sam68 siRNAs were stained by propidium iodide (PI) and Annexin V, followed by flow cytometry analysis. Percentages of relative cell numbers, cells in early apoptosis (PI− Annexin V+), and late apoptosis (PI+ Annexin V+) were quantified, respectively. C, Representative microphotographs of anchorage‐independent growth of A431 cells expressing either si‐NC or si‐Sam68 siRNAs, taken 3 weeks post siRNA transfection. Scale bars, 5 mm. Each experiment contained at least three replicates per condition, and every experiment was performed at least three times. D‐E, Quantification of anchorage‐independent grown colony numbers (D) and areas (E) of A431 cells, as in (C), from six random fields. Data information: In (B, D‐E), data are presented as mean ± SEM. *P < .05; **P < .01; ***P < .001; ****P < .0001 (Student's t test)

Sam68 is essential for mouse skin tumor development and survival

To assess the impact of Sam68 in skin tumor development and survival, we next examined onset of ear lesions and epidermal hyperplasia in Gli2^tg/+ mice in the presence and absence of Sam68. Consistent with our previous report, lesions arise with complete penetrance between P45 and P180 in Gli2^tg/+; Sam68^± mouse ear skin, but with no apparent discordance between the sexes (Figure A,B). In comparison to Gli2^tg/+; Sam68^± mice, Gli2^tg/+; Sam68^‐/‐ mice exhibited a significant delay in the onset of ear skin lesions (Figure A,B). Moreover, the delay of skin tumorigenesis in Gli2^tg/+; Sam68^‐/‐ mice correlated with profound reductions in several key determinants of tumor growth, including morphology of ear tissue (Figure C) and blood vessel expansion (Figure A,D). Thus, these results suggest an essential role of Sam68 in the skin tumor growth and survival in Gli2^tg/+ mice.

Sam68 plays a critical role for mouse development of skin cancer. A, Representative macrographs of P70 ears from the mice with indicated genders and genotypes. Arrows point to blood vessels. Scale bars, 1 cm. B, The tumor lesion onset kinetics in Gli2tg/+;Sam68± and Gli2tg/+;Sam68−/− mice. **P < .02 by Gehan‐Breslow‐Wilcoxon test. C, Hematoxylin and eosin staining of P70 ear tissue sections derived from mice with indicated genotypes. Scale bar, 1 mm. D, Immunofluorescence micrographs of PECAM‐1, with nuclei counterstained by DAPI, on P70 ear tissue sections from Gli2tg/+;Sam68± and Gli2tg/+;Sam68−/− mice. T, tumor; derm, dermis; epi, epidermis. Scale bars, 100 μm. Data information: In (B), **P < .02 (Gehan‐Breslow‐Wilcoxon test)

Sam68 regulates DNA damage signaling pathways in skin cells

We recently reported that Sam68 is an important early DNA damage signaling molecule that regulates DNA damage‐induced activation of poly(ADP‐ribose) polymerase 1 (PARP1) thus fulfilling an essential function in DNA repair and NF‐κB activation signaling pathways. As tumor cells generally acquire enhanced DNA repair activities to overcome the intrinsic DNA damage that frequently occurs during rapid proliferation, we sought to examine whether elevated levels of Sam68 in NMSC are essential for the cellular responses to DNA damage. As expected, γ‐irradiation (IR) triggered a robust PAR chain synthesis in immortalized mouse keratinocytes transfected with nonspecific control siRNA, peaking at 10 minutes posttreatment (Figure A). However, IR‐induced PAR chain formation was markedly dampened in the immortalized mouse keratinocytes with downregulated Sam68 (Figure A). Moreover, in comparison to controls, the phosphorylation of Chk1 and Chk2, two essential signaling transducers in cellular response to DNA damage, was attenuated in Sam68 knockdown keratinocytes (Figure B), supporting a key role of Sam68 in DNA repair signaling in response to DNA damage in keratinocytes.

Sam68 is essential for DNA damage‐induced DNA repair and NF‐κB signaling pathways. A‐D, Immortalized keratinocytes were transfected with nonspecific control (si‐NC) or Sam68‐specific (si‐Sam68) small interference RNAs. Seventy‐two hours later, whole cell lysates were derived at the indicated periods post 4 Gy of γ‐irradiated (IR) and immunoblotted (IB) for indicated proteins, with β‐actin as a loading control. p‐Chk1, phosphorylated Chk1; p‐Chk2, phosphorylated Chk2; p‐p65, phosphorylated p65. E, Survival fraction of keratinocytes at 96‐h posttreatment with indicated doses of γ‐irradiation (IR). F, Schematic model representation of Sam68 functioning as regulator of DNA damage responses through controlling PAR synthesis in normal and cancerous keratinocytes. Data information: In (E), data are presented as mean ± SEM, ns, nonsignificant difference, and *P < .05; ***P < .001 (Student's t test)

We further examined the impact of Sam68 on NF‐κB activation signaling pathway, another important mediator of cellular responses to DNA damage. As expected, IR triggered IκBα degradation, which is a prerequisite for the nuclear translocation of p65, in a time‐dependent manner in control keratinocytes (Figure C). In contrast, DNA damage‐induced IκBα degradation was attenuated in Sam68 knockdown keratinocytes (Figure C). Consistently, phosphorylated p65 (p‐p65), another biochemical hallmark of NF‐κB activation, was also tempered in Sam68 knockdown keratinocytes in comparison to control cells (Figure D). These results hence suggest that Sam68 is essential for DNA damage‐induced NF‐κB activation signaling pathway in skin keratinocytes. To assess the relevance of DDR deficiency caused by Sam68 knockdown, we examined the effect of Sam68 knockdown on clonogenic survival of mouse keratinocytes following exposure to IR. Indeed, Sam68 knockdown in keratinocytes led to an increased sensitivity to IR, compared with control cells (Figure E). Altogether, our results suggest that Sam68 is pivotal for DNA damage‐initiated repair and NF‐κB signaling pathways thus conferring the sensitivity of keratinocytes to DNA damaging agents (Figure F).

DISCUSSION

Since its original identification as the first mitotic substrate and binding partner of Src tyrosine kinase, Sam68 has been reported to fulfill versatile functions in an array of important cellular processes including RNA metabolism, adipogenesis, gametogenesis, transcription, and others. More importantly, an increasing number of studies support an emerging role of Sam68 in tumor progression and development ; in particular, we recently uncovered that Sam68 is a key regulator of the DNA damage sensor PARP1 and plays an indispensable role in the very early cellular signaling cascade in response to DNA damage. Herein, we report that Sam68 regulates DNA damage‐initiated DNA repair and NF‐κB signaling pathways in keratinocytes and that Sam68 is crucial for the growth and survival of skin tumors in mice, which suggests a novel role of Sam68 in the development of NMSC and lends additional support to the pro‐oncogenic properties of Sam68. Our current work has added NMSC to the wide spectrum of cancers in which Sam68 expression is significantly elevated and correlates with tumor progression, including colon cancer, adult myeloid leukemia, oral tongue cancer, breast cancer, renal cell carcinoma, and now, nonmelanoma skin cancer (this study). The evidence herein reported suggests that Sam68, given a ubiquitous expression pattern, could serve as a general prognostic marker for multiple cancers. Future efforts should be devoted to decipher the full significance and mechanisms involved in relating Sam68 to cancer development.

DNA damage constantly occurs in the cell, and accordingly, the cellular DDR machinery has evolved to deal effectively with this challenge. Cancer cells possess a greater propensity to accumulate DNA damage, owing to massive intrinsic DNA damage that occurs during rapid DNA replication and cell proliferation; hence, cancer cells generally acquire hyperactivated DDR machinery and elevated DNA repair capability. Frequently, traditional cancer treatments entail chemotherapy and radiotherapy that target DDR in cancer cells; however, such approaches can also result in damage to normal tissues and unwanted side effects. To kill cancer cells specifically and effectively, it might prove ideal to target the unique abnormalities in the DDR machinery that specifically exists in cancer cells but not healthy normal cells. As a key early signaling regulator at the proxy of the nuclear‐initiated DNA repair and NF‐κB signaling pathway, Sam68 could provide a novel target for therapeutics more selective for cancers. Here, we report that Sam68 knockdown sensitizes human malignant keratinocytes to DNA damaging agents and Sam68 deletion markedly retards skin tumor burden and survival in Gli2^tg/+ mice. These results indicate that Sam68 could potentially be a novel therapeutic target for the treatment of NMSC.

ACKNOWLEDGMENTS

We thank the Wan Lab members for insightful discussions and critical reading of the manuscript. This work was supported in part by Grants R01GM111682 (FW), R01CA160255 (PAC), T32CA009110 (RPH) from the National Institutes of Health (USA), and 2018RS3027 (KF) from Hunan Provincial Science and Technology Department (China). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

CONFLICT OF INTEREST

The authors have no conflict of interest to report.

AUTHOR CONTRIBUTIONS

KF, XS, PAC, and FW designed the experiments. KF and XS conducted most experiments, acquisition of data, and contributed equally. XX, YG, and RPH helped with some experiments. All authors contributed to analysis and interpretation of data. KF and FW wrote the manuscript with input from all authors.